Emvision Medical Devices Ltd. has released a press release.
emu Pivotal Trial Expansion Adds Acute Ischaemia Detection
Earlier from Emvision Medical Devices
- $3.8m R&D Rebate Received & Overseas Finding Approved
- Update - S&P DJI March 2026 Rebalance of the All Ordinaries
- S&P DJI Announces March 2026 Quarterly Rebalance
- EMVision Medical Devices to Present at Australia Investor Day February 26th
